✦ LIBER ✦

PLD-118: TOLERABILITY, SAFETY AND PHARMACOKINETICS AFTER MULTIPLE ORAL DOSING IN HEALTHY MALE VOLUNTEERS

✍ Scribed by A. Schroedter; A. Bischoff; K. Oreskovic; J. Knoeller; W. Schoenfeld; J. Peterson

Book ID: 108913929
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 221 KB
Volume: 45
Category: Article
ISSN: 0933-7407
DOI: 10.1111/j.1439-0507.2002.tb04710.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PLD-118: TOLERABILITY, SAFETY AND PHARMA

PLD-118: TOLERABILITY, SAFETY AND PHARMACOKINETICS FOLLOWING SINGLE ORAL DOSE IN HEALTHY VOLUNTEERS

✍ A. Schroedter; A. Bischoff; K. Oreskovic; W. Schoenfeld; J. Knoeller 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Safety, tolerability and pharmacokinetic

Safety, tolerability and pharmacokinetics of higher-dose mizoribine in healthy male volunteers

✍ Daria Stypinski; Mohammad Obaidi; Michelle Combs; Meg Weber; Adrian J. Stewart; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

Ibudilast in healthy volunteers: safety,

Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses

✍ Paul Rolan; Jacqueline A. Gibbons; Lin He; Eppie Chang; Drew Jones; Matthew I. G 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 761 KB

Pharmacokinetics and safety of oral almo

Pharmacokinetics and safety of oral almotriptan in healthy male volunteers

✍ J. McEwen; M. Salva; J.M. Jansat; X. Cabarrocas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

The single dose pharmacokinetics and saf

The single dose pharmacokinetics and safety of deramciclane in healthy male volunteers

✍ Harri Kanerva; Olavi Kilkku; Esa Heinonen; Antti Helminen; Juha Rouru; Simo Tarp 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 2 views

The pharmacokinetics and tolerability of a new putative non-benzodiazepine type anxiolytic compound deramciclane was studied in two consecutive studies. An open dose-escalation design was used to study doses from 0.2 to 50 mg in 18 healthy male volunteers. In the second study doses from 50 to 150 mg

Pharmacokinetics and safety of binodenos

Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers

✍ Richard J. Barrett; Michael J. Lamson; James Johnson; William B. Smith 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 181 KB

## Background: Binodenoson, a highly selective agonist of the adenosine a 2a receptor, is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging. this study was designed to assess the single-dose pharmacokinetics, safety, and tolera